In accordance with the regulations adopted pursuant to NRS 682A.388, the Commissioner may approve additional transactions involving the use of derivative instruments in excess of the limits of NRS 682A.562 or for other risk-management purposes, but replication transactions must not be allowed for other than risk-management purposes.
(Added to NRS by 2015, 3463)